Contact
searchSearch
HMP Global
Videos

Image-Guided Cryoablation of Extra-Axial Desmoid Tumors: Supplemental Video Series

04/10/2020

Related Content

Case Report and Review
Cryoablation of Abdominal Wall Desmoid Tumor
07/01/2022
Steven Yevich, MD, MPH; Mahmoud A. Ali, MD
A 30-year-old woman presented with a 4 x 2-cm desmoid tumor, which increased in size to 5 x 4 cm over the next several months. The patient was subsequently treated with 2 sessions of cryoablation, which resulted in complete tumor response at...
A 30-year-old woman presented with a 4 x 2-cm desmoid tumor, which increased in size to 5 x 4 cm over the next several months. The patient was subsequently treated with 2 sessions of cryoablation, which resulted in complete tumor response at...
A 30-year-old woman presented...
07/01/2022
Vascular Disease Management
Press Release
NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors
10/26/2020
BASEL, Switzerland, Oct. 26, 2020 /PRNewswire/ -- NBE-Therapeutics, a Swiss-based company developing best-in-class cancer therapies based on its proprietary, highly differentiated Antibody-Drug Conjugate (ADC) platform, today...
BASEL, Switzerland, Oct. 26, 2020 /PRNewswire/ -- NBE-Therapeutics, a Swiss-based company developing best-in-class cancer therapies based on its proprietary, highly differentiated Antibody-Drug Conjugate (ADC) platform, today...
BASEL, Switzerland, Oct....
10/26/2020
Vascular Disease Management
Clinical Insights
Image-Guided Cryoablation of Extra-Axial Desmoid Tumors in 3 Patients
04/17/2020
Lina Elsamaloty, MD; Ben Hammelman, MD
ABSTRACT: Desmoids are a benign connective tissue tumor that can grow aggressively, causing discomfort and impairing function.  Surgical resection can incur significant morbidity, and there is a high rate of recurrence due to microscopic...
ABSTRACT: Desmoids are a benign connective tissue tumor that can grow aggressively, causing discomfort and impairing function.  Surgical resection can incur significant morbidity, and there is a high rate of recurrence due to microscopic...
ABSTRACT: Desmoids are a benign...
04/17/2020
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest
Imaging of acute ischemic stroke
Stroke Treatment
Siemens Healthineers Receives ARPA-H Funding of up to $31M to Advance Remote Endovascular Robotics for Acute Stroke Treatment
08/20/2026
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential...
08/20/2026
Cath Lab Digest
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest
JANE-2 project
Green Paper
Tumor Ablation Review Maps Next Phase of Cancer Care
08/14/2026
Laura Simson, MA
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of...
08/14/2026
Vascular Disease Management
Intravascular Lithotripsy
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero Peripheral IVL System
08/12/2026
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will...
08/12/2026
Cath Lab Digest
Embolic Technologies
Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform
08/12/2026
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6,...
08/12/2026
Vascular Disease Management
Phase 3 Randomized Clinical Trial
TACE Plus Ablation Improves Survival in Unresectable HCC Compared With TACE Alone
08/11/2026
Laura Simson, MA
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency...
08/11/2026
Vascular Disease Management
CANSCAN Participant using VxWave
autonomous Ultrasound Imaging
Vexev Raises $6M to Accelerate U.S. Commercialization of Autonomous Vascular Imaging Platform
08/10/2026
The announcement follows successful results in a multi-site clinical study with U.S. Renal Care, one of the nation's largest dialysis providers, showing early clinical validation of VxWave in routine dialysis clinic workflows.
The announcement follows successful results in a multi-site clinical study with U.S. Renal Care, one of the nation's largest dialysis providers, showing early clinical validation of VxWave in routine dialysis clinic workflows.
The announcement follows...
08/10/2026
Cath Lab Digest
Press Release
Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device
07/24/2026
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026...
07/24/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use